These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8921261)

  • 1. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo.
    Arenas E; Akerud P; Wong V; Boylan C; Persson H; Lindsay RM; Altar CA
    Eur J Neurosci; 1996 Aug; 8(8):1707-17. PubMed ID: 8921261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra.
    Altar CA; Boylan CB; Fritsche M; Jackson C; Hyman C; Lindsay RM
    Exp Neurol; 1994 Nov; 130(1):31-40. PubMed ID: 7821394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine.
    Martin-Iverson MT; Todd KG; Altar CA
    J Neurosci; 1994 Mar; 14(3 Pt 1):1262-70. PubMed ID: 8074747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous behaviours of rats are differentially affected by substantia nigra infusions of brain-derived neurotrophic factor and neurotrophin-3.
    Martin-Iverson MT; Altar CA
    Eur J Neurosci; 1996 Aug; 8(8):1696-706. PubMed ID: 8921260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon.
    Hyman C; Juhasz M; Jackson C; Wright P; Ip NY; Lindsay RM
    J Neurosci; 1994 Jan; 14(1):335-47. PubMed ID: 8283241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
    Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
    J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo.
    Hagg T
    Exp Neurol; 1998 Jan; 149(1):183-92. PubMed ID: 9454627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions.
    Volpe BT; Wildmann J; Altar CA
    Neuroscience; 1998 Apr; 83(3):741-8. PubMed ID: 9483558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.
    Altar CA; Boylan CB; Jackson C; Hershenson S; Miller J; Wiegand SJ; Lindsay RM; Hyman C
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11347-51. PubMed ID: 1454818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
    Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
    Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909.
    Sivam SP
    Brain Res Mol Brain Res; 1996 Jan; 35(1-2):197-210. PubMed ID: 8717356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic organization of GABAergic inputs from the striatum and the globus pallidus onto neurons in the substantia nigra and retrorubral field which project to the medullary reticular formation.
    von Krosigk M; Smith Y; Bolam JP; Smith AD
    Neuroscience; 1992 Oct; 50(3):531-49. PubMed ID: 1279463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts.
    Sauer H; Fischer W; Nikkhah G; Wiegand SJ; Brundin P; Lindsay RM; Björklund A
    Brain Res; 1993 Oct; 626(1-2):37-44. PubMed ID: 8281451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
    Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo.
    Shen RY; Altar CA; Chiodo LA
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8920-4. PubMed ID: 8090745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence.
    Somers DL; Beckstead RM
    Brain Res Mol Brain Res; 1990 Jul; 8(2):143-58. PubMed ID: 1698246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
    Lapchak PA; Miller PJ; Collins F; Jiao S
    Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.
    Sivam SP; Breese GR; Krause JE; Napier TC; Mueller RA; Hong JS
    J Neurochem; 1987 Nov; 49(5):1623-33. PubMed ID: 2889804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
    You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
    Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons.
    Bannon MJ; Lee JM; Giraud P; Young A; Affolter HU; Bonner TI
    J Biol Chem; 1986 May; 261(15):6640-2. PubMed ID: 2422168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.